Savonix Inc., a San Francisco, CA-based developer of an evidence-based digital neuro-cognitive assessment and brain health platform, closed $1.5m in seed funding.
The round was led by RoundGlass Partners with participation from Kickstart Seed Fund, BMNT Capital, and strategic San Francisco-based angel investors Bandel Carano and Connecticut based, Ed Glassmeyer, among others.
The company intends to use the funds to hire new people and to launch and scale its flagship assessment product.
Led by Dr. Mylea Charvat, CEO and Founder, Savonix is building a mobile neuro-cognitive assessment and brain health platform, which will allow end users to conduct a full clinically recognized cognitive assessment directly from their mobile device in half an hour. The platform will also enable individuals, employers, healthcare and primary care physicians to evaluate and leverage results augmented by a suite of complementary tools to improve brain health.